NCT06116409

Brief Summary

TAPA is a new analgesic block technique that involves the injection of local anesthetics into the thoracoabdominal nerves using a perichondrial approach. Application to the undersurface of the rib cartilage is considered as Modified TAPA (M-TAPA). These techniques are commonly applied for postoperative analgesia in surgeries and are effective and safe when performed under ultrasound guidance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for not_applicable postoperative-pain

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 20, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 3, 2023

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 24, 2023

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
Last Updated

March 2, 2026

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

October 20, 2023

Last Update Submit

February 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluate patients' postoperative pain

    The primary aim of this study is to evaluate and compare the postoperative analgesic effectiveness of modified thoracoabdominal nerve block (M-TAPA) in total laparoscopic hysterectomy. Numerical rating scale (NRS) will be used for postoperative analgesic effectiveness. NRS ranging from 0 (no pain) to 10 (worst imaginable pain) will be used for pain assessment.NRS assessed at 2, 6, 12, and 24 hours postoperatively.

    postoperative 24 hours

Secondary Outcomes (1)

  • Number of Participants Requiring Rescue Tramadol Within 24 Hours Postoperatively

    Up to 24 hours postoperatively

Study Arms (2)

M-TAPA GROUP

EXPERIMENTAL

Group 1 patients will receive a modified thoracoabdominal nerve block (M-TAPA) with a perichondrial approach using 40 ml of 0.25% bupivacaine guided by ultrasound (US).

Drug: Bupivacain

CONTROL GROUP

NO INTERVENTION

Patients in Group 2 (the control group) will receive routine multimodal analgesia, which includes tramadol at a dose of 1 mg/kg and paracetamol at a dose of 15 mg/kg.

Interventions

Bupivacaine was used for postoperative analgesia block.

M-TAPA GROUP

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • electively total laparoscopic hysterectomy operations
  • ASA II-III,
  • between 18-65 years

You may not qualify if:

  • ASA IV and above • over 65 - under 18 years of age allergy to local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Science, Kartal Dr Lütfi Kırdar Training and Research Hospital

Istanbul, Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • hülya yılmaz ak

    Kartal Dr Lutfi Kırdar City Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
specialist medical doktor

Study Record Dates

First Submitted

October 20, 2023

First Posted

November 3, 2023

Study Start

September 1, 2023

Primary Completion

November 24, 2023

Study Completion

November 30, 2023

Last Updated

March 2, 2026

Record last verified: 2025-02

Locations